The group's annual meeting heads to Atlanta this April. TAVR, GLP-1 agonists, medical imaging guidance and blood pressure control are just some of the topics that will be presented during late-breaking sessions.

While 96% of first-time test takers passed the ABIM's subspecialty exam in cardiovascular disease in 2018, that number dropped to 86% in 2021 and 2022.

Paravalvular leak remains a significant problem after TAVR, SAVR and even TMVR. Could a new-look interventional technique help heart teams overcome this issue and improve patient outcomes? 

Performing two procedures at once does not appear to make a significant impact on patient safety, though it may lead to a few new risks sure to interest heart teams. 

A majority of strokes after TAVR occur in the first 48 hours, but patients remain at a significantly higher risk for much longer. 

Congress has already adjourned for the year without taking action, but U.S. medical societies are hoping relief from significant Medicare cuts will arrive in early 2024. 

Cardiovascular disease remains one of the leading causes of mortality in the world, responsible for nearly 20 million deaths in 2022 alone. 

Adolph M. Hutter, MD, spent more than 50 years with Massachusetts General Hospital and worked with multiple professional sports teams. In addition, he served as president of the American College of Cardiology in 1992-1993.